Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
Int J Antimicrob Agents. 2020 Jun 13;:106052
Authors: Hong SI, Ryu BH, Chong YP, Lee S, Kim S, Kim HC, Hong KW, Bae IG, Cho OH
PMID: 32544570 [PubMed - as supplied by publisher]